23 results
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
Summary table of ... commonly used diabetic ... #pharmacology #dm2 ... #diabetes #medications ... #overview #management
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Brief Overview of ... Treatment Agents ... #Medications #Treatment ... #COVID19 #Pharmacology ... #Table #Management
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... #pharmacology #pharmacotherapy ... #table #comparison ... #management #medications ... #treatment
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
chronic hepatitis C virus ... DAAs #Antivirals #table ... #treatment #hcv ... HepC #HepatitisC #Management ... #Pharmacology
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
SARS-CoV-2, the virus ... here is a quick overview ... EmergencyMedicine #Pharmacology ... #Treatment #Virus ... #Antiviral #Management
Emergency Therapy of Hyperkalemia
Therapy - Dose and Route - Onset of Action - Duration of Effect
Hyperkalemia Therapy - Dose ... #Hyperkalemia #management ... #pharmacology # ... table #treatment
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
be considered (doses ... PO in 2 divided doses ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
Management of Diabetes ... increase in the dose ... initiation of treatment ... an increase in dose ... evidence-based pharmacologic
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
mucoadhesive buccal tablet ... chew, or crush tablet ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Achieve a total dose ... Leishmaniasis #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology